ALLR

NASD Allarity Therapeutics, Inc.
Oct 14, 2026 · 2:04 AM ET EOD Market Closed

$0.8699 ↑ +0.0000 (+0.00%) Trading Up from the previous close of $0.8699, $0.0401 below the day’s high of $0.9100

YTD change
-19.45%
vs 20-day SMA
-16.91%
vs 200-day SMA
-29.55%

Price ranges

Previous day
$0.8319 $0.9900
open $0.9700 close $0.8601
-$0.1099 (-11.33%)
Today
$0.8303 $0.9100
open $0.8800 now $0.8699
-$0.0101 (-1.15%)
Past week
$0.8319 $1.0400
from $1.0000 now $0.8699
-$0.1301 (-13.01%)
Past month
$0.8319 $1.2666
from $1.1700 now $0.8699
-$0.3001 (-25.65%)
This year
$0.7687 $1.8395
from $1.0800 now $0.8699
-$0.2101 (-19.45%)

Price & Performance

-0.32 (-26.90%) / 6M

$0.7873$1.14$1.49$1.84Apr 13Jul 14Oct 13

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Poor
  • The stock is 100.0% away from all-time highs of $764,400.0000
  • ALLR is down 19% since the beginning of the year
  • ALLR is down 43% over the past 12 months
  • ALLR is down 26% over the past 1 month
  • 1% of all ALLR investors are betting against ALLR

ALLR reads poor: price sits below both the 20- and 200-day averages, the 12-month move is -43.1%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-0.21
Earnings momentum N/A Quarterly EPS growth
Quarterly change N/A

Valuation

P/E ratio N/A
Enterprise value $9.0M
Beta 0.89

Balance sheet & scale

IncomeN/A
Revenue$345.0K
Cash$27.0M
Debt$22.3K
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Manufacturing
Sub Sector Chemical Manufacturing
Market cap $13.8M

Allarity Therapeutics, Inc. is a clinical-stage biopharmaceutical company dedicated to developing personalized cancer treatments. The company is focused on development of stenoparib, a novel PARP and tankyrase inhibitor for advanced ovarian cancer patients, using its DRP technology to develop a companion diagnostic that can be used to select those patients expected to derive the greatest clinical benefit from stenoparib. Allarity Therapeutics was founded by Steen Knudsen and Thomas H. Jensen in 2004 and is headquartered in Tarpon Springs, FL.

Competitor comparison

TickerCompany PriceChange
LLY Eli Lilly and Company $1,166.51 -1.36%
JNJ Johnson & Johnson $248.61 -5.73%
ABBV AbbVie, Inc. $274.36 -2.40%
MRK Merck & Co., Inc. $141.98 -2.39%
RHHVF Roche Holding Ltd $438.07 +1.80%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.